Fed bans ex-Goldman managing director over supervisory info misuse
By 
Kyle Brasseur2022-04-08T13:25:00
The Federal Reserve Board permanently barred from the banking industry former Goldman Sachs Managing Director Joseph Jiampietro after he allegedly misused confidential supervisory information to further his regulatory advisory practice.
Related articles
-
News BriefProbe into Goldman Sachs’ credit card practices expands
Goldman Sachs Group disclosed more regulators—beyond the Consumer Financial Protection Bureau—are investigating its credit card account management practices.
-
Blog
Fed hits Goldman Sachs over use of supervisory information
The Federal Reserve Board has ordered Goldman Sachs Group to pay a $36.3 million civil penalty for the unauthorized use and disclosure of confidential supervisory information in presentations to clients and prospective clients. Joe Mont reports.
-
News BriefTrump-era deregulation cuts OSHA enforcement powers on workplace hazards
The U.S. Department of Labor scaled back OSHA penalties for small businesses and limited use of the general duty clause as part of the Trump administration’s deregulation agenda.
More from Regulatory Enforcement
-
News BriefDelta to pay $8.1 million over False Claims Act violations tied to pandemic aid
Delta Air Lines agreed to pay $8.1 million over allegations it violated the False Claims Act by exceeding employee compensation limits it agreed to when taking federal pandemic aid money.
-
News BriefDOJ and CFTC close investigations into crypto betting platform Polymarket, report says
The U.S. Department of Justice (DOJ) and the Commodity Futures Trading Commission (CFTC) reportedly ended two investigations into Polymarket, a popular online crypto betting service that calls itself a “prediction market.” The move continues the Trump administration’s pro-crypt agenda.
-
News BriefFTC fines telehealth firm over deceptive weight-loss claims and fake reviews
The U.S. Federal Trade Commission said it has settled with telemedicine service Southern Health Solutions, Inc. over allegations the company used deceptive pricing and weight-loss claims, along with fake reviews and testimonials, to sell its weight-loss programs.